abagovomab 18
abciximab 16
abituzumab 17
abrilumab 7
actoxumab 7
adalimumab 11
aducanumab 7
afasevikumab 5
alacizumab_pegol 7
alemtuzumab 19
alirocumab 9
amatuximab 23
andecaliximab 15
anifrolumab 9
anrukinzumab 13
aprutumab 9
aprutumab_ixadotin 9
arcitumomab 11
ascrinvacumab 4
atezolizumab 13
atinumab 10
avelumab 7
basiliximab 13
bavituximab 14
begelomab 12
benralizumab 13
bevacizumab_beta 10
bezlotoxumab 7
bimagrumab 8
bleselumab 4
blinatumomab 15
blosozumab 22
bococizumab 11
brazikumab 9
brentuximab_vedotin 9
briakinumab 14
brodalumab 4
brolucizumab 17
brontictuzumab 10
burosumab 12
cabiralizumab 13
camrelizumab 8
canakinumab 19
cantuzumab_ravtansin 22
carlumab 11
carotuximab 8
cergutuzumab_amunaleukin2 18
cergutuzumab_amunaleukin 18
certolizumab_pegol 14
cetiximab 23
citatuzumab_bogatox 21
cixutumumab 13
clivatuzumab_tetraxetan 3
codrituzumab 13
conatumumab 5
concizumab 15
crenezumab 8
crizanlizumab 13
crotedumab 11
dacetuzumab 16
daclizumab 10
dalotuzumab 19
dapirolizumab_pegol 16
daratumumab 11
dectrekumab 8
demcizumab 13
denosumab 8
depatuxizumab 13
depatuxizumab_mafodotin 13
dezamizumab 10
dinutuximab 22
diridavumab 6
domagrozumab 12
drozitumab 4
duligotuzumab 11
durvalumab 4
dusigitumab 0
efalizumab 17
efungumab 12
eldelumab 6
elezanumab 3
elgemtumab 6
elotuzumab 8
emactuzumab 12
emapalumab 13
emibetuzumab 9
enavatuzumab 21
enfortumab_vedotin 5
enoblituzumab 13
enokizumab 15
enoticumab 11
ensituximab 13
eptinezumab 11
erenumab 0
etaracizumab 13
etrolizumab 13
evinacumab 13
evolocumab 3
farletuzumab 3
fasinumab 15
fezakinumab 6
fibatuzumab 3
ficlatuzumab 10
firivumab 19
flanvotumab 5
fletikumab 11
foralumab 6
foravirumab 8
fremanezumab 20
fresolimumab 16
fulranumab 13
futuximab 7
galcanezumab 6
ganitumab 12
gantenerumab 4
gemetuzumab 16
gemtuzumab2 13
gemtuzumab 14
gevokizumab 17
girentuximab 10
glembatumumab 6
glembatumumab_vedotin 6
guselkumab 16
ibalizumab 15
ibritumomab 9
icrucumab 5
idarucizumab 14
ifabotuzumab 3
imalumab 13
imgatuzumab 8
inclacumab 6
indatuximab_ravtansin 14
indusatumab 6
inebilizumab 18
intetumumab 5
iodine_girentuximab 24
ipilimumab 0
iratumumab 4
isatuximab 12
itolizumab 16
ixekizumab 16
labetuzumab_govitecan 14
lambrolizumab 17
lampalizumab 13
lanadelumab 13
landogrozumab 9
laprituximab 15
lebrikizumab 17
lendalizumab 16
lenzilumab 8
lifastuzumab_vedotin 17
ligelizumab 18
lilotomab 11
lirilumab 4
lodelcizumab 8
lokivetmab 14
lorvotuzumab_mertansin 7
lucatumumab 20
lumretuzumab 6
lupartumab 7
lutikizumab 12
margetuximab 21
milatuzumab 15
mirvetuximab 15
mirvetuximab_soravtansin 15
modotuximab 20
mogamulizumab 18
monalizumab 15
motavizumab 18
moxetumomab_pasudotox 13
namilumab 8
naratuximab 13
naratuximab_emtansin 13
narnatumab 10
navicixizumab2 18
navicixizumab 17
navivumab 17
necitumumab 6
nemolizumab 16
nesvacumab 9
nivolumab 7
obiltoxaximab 7
obinutuzumab 21
ocaratuzumab 14
ofatumumab 6
olaratumab 4
olokizumab 18
omalizumab 15
onartuzumab 9
ontuxizumab 3
opicinumab 11
orticumab 4
otelixizumab 25
oxelumab 6
ozanezumab 15
pamrevlumab 4
panobacumab 9
parsatuzumab 15
pasotuxizumab 17
pateclizumab 8
patritumab 9
pembrolizumab 17
perakizumab 12
pidilizumab 12
pinatuzumab_vedotin 8
plozalizumab 20
pogalizumab 13
polatuzumab_vedotin 11
ponezumab 20
prezalumab 10
pritoxaximab 11
quilizumab 10
racotumomab 15
radretumab 12
ralpancizumab 16
ramucirumab 10
ranevetmab 15
ranibizumab 7
refanezumab 14
remtolumab 9
rilotumumab 7
rinucumab 10
risankizumab 23
rituximab 6
rivabazumab 10
robatumumab 18
roledumab 15
romosozumab 14
rontalizumab 11
rosmantuzumab 9
rozanolixizumab 10
sacituzumab 12
sacituzumab_govitecan 12
samalizumab 14
sapelizumab 16
sarilumab 9
secukinumab 8
seribantumab 9
setoxaximab 23
sifalimumab 3
siltuximab 12
simtuzumab 14
sirukumab 6
solanezumab 18
solitomab 10
stamulumab 10
suptavumab 13
suvizumab 4
tabalumab 5
tadocizumab 4
tamtuvetmab 21
tanezumab 16
tarextumab 7
tavolixizumab 9
telisotuzumab 17
teplizumab 6
tesidolumab 11
tezepelumab 15
tigatuzumab 12
tildrakizumab 14
timolumab 5
tisotumab 3
tosatoxumab 17
tositumomab 9
tralokinumab 12
trastuzumab 17
tregalizumab 16
trevogrumab 8
ublituximab 12
urelumab 10
ustekinumab 15
utomilumab 16
vadastuximab 17
vadastuximab_talirin 17
vandortuzumab_vedotin 4
vantictumab 9
vanucizumab2 10
vanucizumab 14
varlilumab 10
vatelizumab 15
vedolizumab 8
veltuzumab 3
vesencumab 4
vorsetuzumab 12
vorsetuzumab_mafodotin 12
vunakizumab 19
xentuzumab 13
zatuximab 20
